Podcast Episodes
Back to Search
Bets and Balances: Riding the Risk-and-Innovation Pendulum in Biotech
In a podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, and Andrew Hall, CEO of Consano Bio, discuss what eff…
5 months ago
Pharmaceutical Executive Daily: Hims & Hers Removes Access to New Compounded Semaglutide Pill
In today’s Pharmaceutical Executive Daily, Hims & Hers withdraws access to its compounded semaglutide pill following a controversy filled launch, nex…
5 months ago
Pharmaceutical Executive Daily: The Launch of TrumpRx
In today’s Pharmaceutical Executive Daily, TrumpRx officially launches, the FDA moves against mass marketing of illegal copycat drugs, and AI emerges…
5 months, 1 week ago
Pharmaceutical Executive Daily: FDA Approves First and Only Oral Film Treatment for Erectile Dysfunction
In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical protocols should be treat…
5 months, 1 week ago
Pharmaceutical Executive Daily: Susan G. Komen Releases Breast Cancer Outlook for 2026
In today’s Pharmaceutical Executive Daily, Susan G. Komen releases its 2026 breast cancer progress outlook, industry leaders explore how pharma can t…
5 months, 1 week ago
Pharmaceutical Executive Daily: SanegeneBio's $1.5 Billion License Agreement with Genentech
In today’s Pharmaceutical Executive Daily, a new a is expected to evolve in 2026, the FDA rejects AstraZeneca’s application for a subcutaneous indica…
5 months, 1 week ago
Pharmaceutical Executive Daily: FDA Reveals PreCheck Pilot Program
In today’s Pharmaceutical Executive Daily, the FDA introduces a PreCheck pilot program aimed at strengthening domestic manufacturing oversight, an AC…
5 months, 1 week ago
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
In today’s Pharmaceutical Executive Daily, Public Citizen files suit over undisclosed drug pricing agreements involving Pfizer and Eli Lilly, HHS rel…
5 months, 1 week ago
Pharmaceutical Executive Daily: The Disconnect Between Pharma and MedTech
In today’s Pharmaceutical Executive Daily, MJH Life Sciences CEO, Mike Hennessy Jr. examines why pharma and medtech still struggle to deliver truly i…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: Eli Lilly Enters $1 Billion Research Collaboration with Seamless Therapeutics
In today’s Pharmaceutical Executive Daily, Insilico Medicine and Qilu Pharmaceuticals launch a $120 million collaboration to advance AI-driven cardio…
5 months, 2 weeks ago